Targeting DNA-PKcs increased anticancer drug sensitivity by suppressing DNA damage repair in osteosarcoma cell line MG63.
about
Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer TherapyInhibiting DNA-PKCS radiosensitizes human osteosarcoma cells.Drugs in early clinical development for the treatment of osteosarcoma.Translating antibody directed enzyme prodrug therapy (ADEPT) and prospects for combination.DNA-dependent protein kinase catalytic subunit functions in metastasis and influences survival in advanced-stage laryngeal squamous cell carcinoma
P2860
Targeting DNA-PKcs increased anticancer drug sensitivity by suppressing DNA damage repair in osteosarcoma cell line MG63.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting DNA-PKcs increased a ...... n osteosarcoma cell line MG63.
@en
type
label
Targeting DNA-PKcs increased a ...... n osteosarcoma cell line MG63.
@en
prefLabel
Targeting DNA-PKcs increased a ...... n osteosarcoma cell line MG63.
@en
P2093
P2860
P1433
P1476
Targeting DNA-PKcs increased a ...... n osteosarcoma cell line MG63.
@en
P2093
Hongliang Wang
Jianmin Li
Jiguang Tian
P2860
P2888
P304
P356
10.1007/S13277-015-3642-5
P577
2015-06-25T00:00:00Z
P6179
1038897590